Forecyte Bio

Forecyte Bio is a CDMO company founded in 2021 to service the rapidly growing CGT industry. Built on decades of experience and expertise from its core technical team on CGT CMC processes, Forecyte Bio offers a 4×4^TM holistic service package to accelerate clients’ projects, covering 4 technology platforms (plasmid, viral vector, cell product, and RNA) at 4 developmental stages (R&D, PD/AD, GMP, and regulatory filing). Our GMP capacities are available from both Frederick MD and Shanghai China.